HEPATITIS-C VIRUS - THE NEPHROLOGISTS VIEW

被引:117
作者
ROTH, D
机构
[1] Division of Nephrology, University of Miami School of Medicine, Miami, FL
关键词
HEPATITIS C VIRUS; DIALYSIS; TRANSPLANTATION; GLOMERULONEPHRITIS; CRYOGLOBULINEMIA;
D O I
10.1016/0272-6386(95)90617-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The last 4 years have been a period of rapid expansion in our understanding of both the molecular biology and clinical significance of hepatitis C virus (HCV) infection. Initial studies using first-generation enzyme-linked immunosorbent assays suggested that the end-stage renal disease population had an exceptionally high prevalence of anti-HCV compared with asymptomatic healthy blood donors. Subsequent analyses with second-generation assays and polymerase chain reaction techniques to detect viremia confirmed these earlier studies. Considering the prevalence of HCV within the dialysis population, it comes as no surprise that several studies confirmed HCV as the leading cause of non-A, non-B hepatitis among renal allograft recipients. Furthermore, transmission of HCV by transplantation of a kidney from an HCV-infected organ donor has been unequivocally demonstrated. The natural history of HCV infection in the immunosuppressed allograft recipient and its impact on long-term patient outcome are still being analyzed. Finally, HCV has been associated with essential mixed cryoglobulinemia and several histologic patterns of immune complex glomerulonephritis, including membranous and membrano-proliferative glomerulonephritis. Although HCV antigen-antibody complexes have not been demonstrated in the kidney, the marked decrease in proteinuria following clearance of HCV RNA with interferon alpha-2b therapy suggests an etiologic role for HCV in these glomerular diseases. Furthermore, the demonstration of HCV RNA in the cryoprecipitate of patients with essential mixed cryoglobulinemia and a beneficial response to treatment with interferon alpha-2b also suggest a role for HCV in the pathogenesis of these clinical syndromes. (C) 1995 by the National Kidney Foundation, Inc,
引用
收藏
页码:3 / 16
页数:14
相关论文
共 88 条
[1]   HEPATITIS-C VIRUS-INFECTION IN POSTTRANSFUSION HEPATITIS - AN ANALYSIS WITH 1ST-GENERATION AND 2ND-GENERATION ASSAYS [J].
AACH, RD ;
STEVENS, CE ;
HOLLINGER, FB ;
MOSLEY, JW ;
PETERSON, DA ;
TAYLOR, PE ;
JOHNSON, RG ;
BARBOSA, LH ;
NEMO, GJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (19) :1325-1329
[2]   PREVALENCE OF HEPATITIS C VIRUS-ANTIBODIES IN HOSPITAL PERSONNEL [J].
ABB, J .
ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1991, 274 (04) :543-547
[3]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[4]   DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[5]  
ARITA S, 1992, TRANSPLANT P, V24, P1538
[6]   HEPATITIS C-VIRUS (HCV) ANTIBODIES IN PATIENTS AFTER KIDNEY-TRANSPLANTATION [J].
BAUR, P ;
DANIEL, V ;
POMER, S ;
SCHEURLEN, H ;
OPELZ, G ;
ROELCKE, D .
ANNALS OF HEMATOLOGY, 1991, 62 (2-3) :68-73
[7]   PREVALENCE OF HCV ANTIBODIES IN A UREMIC POPULATION UNDERGOING MAINTENANCE DIALYSIS THERAPY AND IN THE STAFF MEMBERS OF THE DIALYSIS UNIT [J].
BESSO, L ;
ROVERE, A ;
PEANO, G ;
MENARDI, G ;
FENOGLIO, LM ;
FENOGLIO, S ;
GHEZZI, PM .
NEPHRON, 1992, 61 (03) :304-306
[8]   TREATMENT OF IDIOPATHIC MIXED CRYOGLOBULINEMIA WITH ALPHA-INTERFERON [J].
BONOMO, L ;
CASATO, M ;
AFELTRA, A ;
CACCAVO, D .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (04) :726-730
[9]   NON-HEPATITIS-B ASSOCIATED LIVER-DISEASE IN A RENAL-TRANSPLANT POPULATION [J].
BOYCE, NW ;
HOLDSWORTH, SR ;
HOOKE, D ;
THOMSON, NM ;
ATKINS, RC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (04) :307-312
[10]  
BURSTEIN DM, 1993, J AM SOC NEPHROL, V4, P1288